NDC 61703-350 – Methotrexate

Methotrexate Sodium 25 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous

Human Prescription Drug 2 recalls

Product NDC61703-350

Product details

Brand name
Methotrexate
Generic name
Methotrexate
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous, Subcutaneous
Marketing category
NDA · NDA011719
Marketed since
September 25, 2014
Listing expires
December 31, 2026
Pharmacologic class
Folate Analog Metabolic Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Methotrexate →

Package NDC codes (2)

Package NDCDescriptionSince
61703-350-105 VIAL, MULTI-DOSE in 1 CARTON (61703-350-10) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-09)Sep 25, 2014
61703-350-385 VIAL, MULTI-DOSE in 1 CARTON (61703-350-38) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-37)Jul 27, 2005

Recalls mentioning this NDC

Other Methotrexate products